Physicochemical and structural characterization of iron–sucrose formulations: a comparative study

References

• Akarsu S, Taskin E, Yilmaz E, et al. Treatment of iron deficiency anemia with intravenous iron preparations. Acta Haematol 2006;116:51–57
   PubMedGoogle Scholar
• Slack HG, Wilkinson JF. Intravenous treatment of anaemia with an iron-sucrose preparation. Lancet 1949;1:11–14
   PubMedGoogle Scholar
• Cancado RD, Munoz M. Intravenous iron therapy: how far have we come? Rev Bras Hematol Hemoter 2011;33:461–469
   PubMedGoogle Scholar
• Sengolge G, Horl WH, Sunder-Plassmann G. Intravenous iron therapy: well-tolerated, yet not harmless. Eur J Clin Invest 2005;35:46–51
   PubMedGoogle Scholar
• Toblli JE, Cao G, Oliveri L, Angerosa M. Differences between original intravenous iron sucrose and iron sucrose similar preparations. Arzneimittelforschung 2009;59:176–190
   PubMed Web of Science ®Google Scholar
• Kudasheva DS, Lai J, Ulman A, Cowman MK. Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations. J Inorg Biochem 2004;98:1757–1769
   PubMed Web of Science ®Google Scholar
• Jahn MR, Andreasen HB, Futterer S, et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm 2011;78:480–491
   PubMed Web of Science ®Google Scholar
• Johnson CA, Mason NA, Bailie GR. Intravenous iron products. ANNA J 1999;26:522–524
   PubMedGoogle Scholar
• Balakrishnan VS, Rao M, Kausz AT, et al. Physicochemical properties of ferumoxytol, a new intravenous iron preparation. Eur J Clin Invest 2009;39:489–496
   PubMed Web of Science ®Google Scholar
• Helenek MJ, Lange RA, Lawrence RP. Bioequivalence test for iron-containing formulations, US Patent 7,169,359; 2007
   Google Scholar
• Meier T, Schropp P, Pater C, et al. Physicochemical and toxicological characterization of a new generic iron sucrose preparation. Arzneimittelforschung 2011;61:112–119
   PubMed Web of Science ®Google Scholar
• Christopher CB, Rangisetty JB. Iron sucrose complexes and method of manufacture thereof, US Patent 7,674,780; 2010
   Google Scholar
• Danielson BG. Structure, chemistry, and pharmacokinetics of intravenous iron agents. J Am Soc Nephrol 2004;15:S93–S98
   PubMed Web of Science ®Google Scholar
• Toblli JE, Cao G, Oliveri L, Angerosa M. Differences between the original iron sucrose complex venofer® and the iron sucrose similar generis®, and potential implications. Port J Nephrol Hypert 2009;23:53–63
   Google Scholar
• Langford JI, Wilson AJC. Scherrer after sixty years: a survey and some new results in the determination of crystallite size. J Appl Crystallogr 1978;11:102–113
   Web of Science ®Google Scholar
• Iron sucrose injection monograph, United States Pharmacopeia 29-National Formulary 24, USP Convention, Rockville; 2006:1179
   Google Scholar
• Shah R, Yang Y, Khan M, Faustino P. Molecular weight determination for colloidal iron by Taguchi optimized validated gel permeation chromatography. Int J Pharm 2008;353:21–27
   PubMedGoogle Scholar
• Kim BH, Shin K, Kwon SG, et al. Sizing by weighing: characterizing sizes of ultrasmall-sized iron oxide nanocrystals using MALDI-TOF mass spectrometry. J Am Chem Soc 2013;135:2407–2410
   PubMedGoogle Scholar
• Gutiérrez L, del Puerto Morales M, José Lázaro F. Magnetostructural study of iron sucrose. J Magn Magn Mater 2005;293:69–74
   Google Scholar
• Koralewski M, Pochylski M, Gierszewski J. Magnetic birefringence of iron oxyhydroxide nanoparticles stabilised by sucrose. J Magn Magn Mater 2011;323:1140–1144
   Google Scholar
• Farkas E, Enyedy EA, Zekany L, Deak G. Interaction between iron(ii) and hydroxamic acids: oxidation of iron(ii) to iron(iii) by desferrioxamine b under anaerobic conditions. J Inorg Biochem 2001;83:107–114
   PubMedGoogle Scholar
• Scheinost AC, Schwertmann U. Color identification of iron oxides and hydroxysulfates. Soil Sci Soc Am J 1999;63:1463–1471
   Web of Science ®Google Scholar
• Scheinost AC, Chavernas A, Barron V, Torrent J. Use and limitations of second-derivative diffuse reflectance spectroscopy in the visible to near-infrared range to identify and quantity Fe oxide minerals in soils. Clays Clay Miner 1998;46:528–536
   Web of Science ®Google Scholar
• te Booy MP, de Ruiter RA, de Meere AL. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry. Pharm Res 1992;9:109–114
   PubMed Web of Science ®Google Scholar
• Siverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. 7th ed. New York: John Wiley and Sons; 2005
   Google Scholar